Report : North America Cardiovascular Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Device [Electrocardiography (ECG), Pacemaker, Stent, Defibrillator, Cardiac Catheter, Guidewire, Heart Valve, Event Monitor, and Others], Application (Coronary Heart Disease, Sudden Cardiac Arrest, Stroke, Cerebrovascular Heart Disease, and Others), and End-User (Hospitals, Ambulatory Surgery Centers, and Cardiac Centers)

Hospitals Segment to Dominate North America Cardiovascular Devices market Forecast to 2028 during 2019–2028

 

According to a new market research study on the North America Cardiovascular Devices market Forecast to 2028 –– by device, application vertical and countries is expected to reach US$ 30,779.03 million by 2028 from US$ 19,680.36 million in 2021. The market is estimated to grow at a CAGR of 6.6% from 2021 to 2028. The report provides trends prevailing in the North America Cardiovascular Devices market along with the drivers and restraints pertaining to the market growth. Increasing prevalence of cardiovascular diseases is the major factor driving the growth of the North America Cardiovascular Devices market. However, issues associated with high cost of products and procedures the growth of North America Cardiovascular Devices market.

 

The North America Cardiovascular Devices market segmented into device, application, end user and country. Based on device the North America Cardiovascular Devices market is segmented into electrocardiography (ECG), pacemaker, stent, defibrillator, cardiac catheter, guidewire, heart valve, event monitor, and others. The event monitor segment is dominated North America Cardiovascular Devices market in 2020.Based on application the North America Cardiovascular Devices market segmented into coronary heart disease, sudden cardiac arrest, stroke, cerebrovascular heart disease and others. The coronary heart disease segment North America Cardiovascular Devices market Dominated in 2020. Based on end-user the North America Cardiovascular Devices market segmented into hospitals, ambulatory surgery centers and cardiac centers. The hospitals segment is dominated North America Cardiovascular Devices market in 2020.Based on country, The North America Cardiovascular Devices market segmented into US, Mexico, Canada. The US is dominated the North America Cardiovascular Devices market in 2020.

                                                    

Medtronic, Boston Scientific Corporation, Abbott, Jhonson and Jhonson Service Inc, General Electric Company,Koninlijke Philips N.V, Siemens Healthineers AG, BD,B.Bruna melsungen AG  and Edwards Lifesciences Corporation are among the leading companies in North America Cardiovascular Devices market. For instance, Jan-2022 Medtronic announced that it would acquire cardiac mapping and ablation technology developer Affera. The company expects the transaction to close in the first half of its 2023 fiscal year. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in dynamic market.

Contact Us
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email Id: sales@businessmarketinsights.com          

 

 

 

Download Free PDF Brochure